Zimmer Biomet Inc. (ZBH)

If there is one voice on Wall Street that we always listen to, it is Stifel's Barry Bannister, and with good reason.

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

Zimmer Biomet Holdings, Inc ZBH reported better-than-expected earnings for the first quarter on Monday.

Live Updates Live Coverage Has Ended Markets Pivot to Ford Earnings 4:03 pm by Gerelyn Terzo The markets failed to turn around, ending the trading session lower across the board and ending a multi-ses...

Zimmer Biomet's stock dropped nearly 10% on the back of soft Q1 results. Despite structural tailwinds, Zimmer Biomet's business is struggling in the face of high interest rates, trade tensions and com...

Zimmer Biomet Holdings, Inc ZBH reported first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77.

Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET Company Participants David DeMartino - SVP, IR Ivan Tornos - President & CEO Suketu Upadhyay - CFO & EV...

While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to ...